Compare STTK & FRBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | FRBA |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | 336 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.6M | 508.6M |
| IPO Year | 2020 | N/A |
| Metric | STTK | FRBA |
|---|---|---|
| Price | $4.56 | $18.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $15.40 | ★ $21.67 |
| AVG Volume (30 Days) | ★ 841.6K | 105.7K |
| Earning Date | 11-05-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | ★ 53.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,000,000.00 | N/A |
| Revenue This Year | N/A | $2.61 |
| Revenue Next Year | $14.28 | $5.91 |
| P/E Ratio | ★ N/A | $9.71 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $14.41 |
| 52 Week High | $8.33 | $21.29 |
| Indicator | STTK | FRBA |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 46.99 |
| Support Level | $4.38 | $17.04 |
| Resistance Level | $7.66 | $19.21 |
| Average True Range (ATR) | 0.39 | 0.65 |
| MACD | -0.02 | -0.14 |
| Stochastic Oscillator | 14.29 | 11.00 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of business. Its services are Business Banking, Personal Banking, Digital Banking, and Lending.